Catalent Pharma Solutions, Inc. (CTLT)

Catalent Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Operating Activities

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Net Income	8.2	-46.7	-40.4	-54	-289.6	-308.1
Depreciation & Amortization	146.2	152.2	129.7	115.5	117.8	132.9
Other Amortization	14.6	19	14.7	10	9.6	9.6
Loss (Gain) From Sale of Assets	-	-	-	-	37.6	-
Asset Writedown & Restructuring Costs	1	5.2	9.8	3.6	177.2	175.8
Stock-Based Compensation	4	2.8	3.7	3.9	2.6	-0.3
Provision & Write-off of Bad Debts	7.7	10.4	9.5	9.5	13.8	14.2
Other Operating Activities	-5.9	21.5	14.7	44.6	73.2	23.8
Change in Accounts Receivable	-22.6	-23.6	-64.9	-18.9	2.8	34.1
Change in Inventory	-9.5	-10.5	1.4	-2	12.9	-10.6
Change in Accounts Payable	-12.4	17.9	7.7	-3.5	10.9	0.8
Change in Other Net Operating Assets	18.6	-9.1	1.8	2.9	62.7	-7
Operating Cash Flow	147.8	137.7	87.9	99.7	233.8	76.2
Operating Cash Flow Growth	73.27%	56.66%	-11.84%	-57.36%	206.82%	-10.67%

Investing Activities

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Capital Expenditures	-99.7	-122.5	-104.2	-87.3	-70.5	-78.2
Sale of Property, Plant & Equipment	3.4	2.9	2.2	4	0.3	2
Cash Acquisitions	-56	-2.5	-457.5	-	-	-
Other Investing Activities	4	-	65	32.9	3.5	-8.1
Investing Cash Flow	-148.3	-122.1	-494.5	-50.4	-66.7	-84.3

Financing Activities

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Short-Term Debt Issued	-	-	-	-	1.1	-
Long-Term Debt Issued	-	672.7	393.3	-	-	104
Total Debt Issued	274.1	672.7	393.3	-	1.1	104
Short-Term Debt Repaid	-	-3.9	-2.9	-3.3	-	-1.4
Long-Term Debt Repaid	-	-708.5	-37	-24.1	-56.7	-90.8
Total Debt Repaid	-305.8	-712.4	-39.9	-27.4	-56.7	-92.2
Net Debt Issued (Repaid)	-31.7	-39.7	353.4	-27.4	-55.6	11.8
Issuance of Common Stock	0.7	1.2	1.1	3.9	0.6	-
Repurchase of Common Stock	-	-	-	-	-	-1.3
Other Financing Activities	-3.2	-10.8	-1.6	-2.6	-1.7	-3.3
Financing Cash Flow	-34.2	-49.3	352.9	-26.1	-56.7	7.2

Net Cash Flow

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Foreign Exchange Rate Adjustments	2.9	1.1	-12.4	17.9	-10.3	-7.6
Net Cash Flow	-31.8	-32.6	-66.1	41.1	100.1	-8.5

Free Cash Flow

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Free Cash Flow	48.1	15.2	-16.3	12.4	163.3	-2
Free Cash Flow Growth	-	-	-	-92.41%	-	-
Free Cash Flow Margin	2.65%	0.84%	-0.96%	0.81%	11.03%	-0.13%
Levered Free Cash Flow	110.06	63.41	96.55	43.85	116.79	104.58
Unlevered Free Cash Flow	198.96	171.6	196.54	137.23	210.25	215.35

Additional Metrics

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Cash Interest Paid	170.3	200.1	172.4	157.6	98.6	169.4
Cash Income Tax Paid	17.4	14.2	23.9	20.6	20.9	18.6

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2014

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2025

Data Sources Report a data error